Abiomed
ABMD
#1112
Rank
NZ$29.35 B
Marketcap
$650.97
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the worldโ€™s smallest heart pump.

P/S ratio for Abiomed (ABMD)

P/S ratio on August 1, 2024 (TTM) : 16.0

According to Abiomed's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 11.2. At the end of 2022 the company had a P/S ratio of 10.4.

P/S ratio history for Abiomed from 2014 to 2022

PS ratio at the end of each year

Year P/S ratio Change
202210.4-36.17%
202116.3-9.61%
202018.097.01%
20199.15-53.98%
201819.930.49%
201715.229.19%
201611.8-6.71%
201512.672.33%
20147.33

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
2.94-81.60%๐Ÿ‡บ๐Ÿ‡ธ USA
8.71-45.54%๐Ÿ‡บ๐Ÿ‡ธ USA
3.89-75.66%๐Ÿ‡บ๐Ÿ‡ธ USA